View clinical trials related to Implant Stability.
Filter by:Statement of the problem: Osseo-integration of dental implants depends mainly on bone regeneration around dental implant. Hyperlipidemia has significant adverse effects on bone health, leading to lower bone mineral density and to higher risk of osteoporosis and bone fracture (Corwin 2003; Pirih, Lu et al. 2012). The effects of hyperlipidemia on bone health may also interfere with dental implant therapy since the host's bone quantity, quality and healing potential play an important role in osseointegration (Fedele, Sabbah et al. 2011; Gaetti-Jardim, Santiago-Junior et al. 2011; Olivares-Navarrete, Raines et al. 2012). Rationale for conducting the research: Hyperlipidemia has been associated with the pathophysiology of major diseases, such as atherosclerosis and osteoporosis. A high cholesterol level has significant adverse effects on bone, including lower bone density, volume and strength. Statins, drugs that lower serum cholesterol levels have beneficial effects on bone metabolism. Since host's bone quantity, quality and healing potential play a crucial role in osseointegration of dental implants, it was hypothesized that hyperlipidemia may negatively affect implant osseointegration.
Implants will be placed in posterior maxilla using two drilling methods; the osseodensification technique and standard drilling protocols. Implant stability will be measured right after implant placement and after 3 months. crestal bone level will be measured after implant placement and after 3 and 9 months.